About Technology Issues FAQ

Links

Official Page

Fixed-duration ibrutinib plus venetoclax for first-line treatment of CLL: primary analysis of the CAPTIVATE FD cohort

Fixed-duration ibrutinib plus venetoclax for first-line treatment of CLL: primary analysis of the CAPTIVATE FD cohort — Distribution of the number of citations over years.

site/software © exaly; All materials licenced under CC by-SA.